Track topics on Twitter Track topics that are important to you
An early-stage biopharmaceutical company, BMT is pioneering the development of novel RNAi therapeutics to prevent and treat age-related macular degeneration based on the company's proprietary technology, asymmetric shorter-duplex siRNA (asiRNA). This novel RNAi technology significantly reduces deleterious side effects triggered by conventional siRNA, especially, the stimulation of the innate immune system, which makes it feasible to use asiRNA for the treatment of age-related macular degeneration, a disease to which RNAi therapeutics could not be developed using conventional siRNAs. Other potential applications for BMT's technology include therapeutics targeting infectious disease, such as herpes simplex virus (HSV), and cancer. A privately held company based in Suwon, South Korea, BMT was established in 2010.
(Technical University of Munich (TUM)) 'Flocking' or 'swarming' behavior is omnipresent in the living world, observed in birds, fish, and even bacteria. Strikingly similar collective action can also b...
Structural biology advances have democratized access to biomolecular snapshots, but high standards must be maintained to ensure their utility.
Isothermal titration calorimetry (ITC) is a technique used to measure and characterise biomolecular binding interactions. It works by directly measuring the heat that is either released or absorbed du...
Gold nanoparticles promise potential improvements in cancer treatment, drug delivery, and gene therapy—with one, major problem.
(Vanderbilt University) Recent microbiological research has shown that plants and animals, including humans, are not autonomous individuals but are holobionts: biomolecular networks that consist of vi...
Plants and animals, including humans, are not autonomous individuals but are holobionts: biomolecular networks that consist of visible hosts plus millions of invisible microbes, recent microbiological...
One of the striking features of self-organization in biomolecular systems is the capacity of assemblies of filamentous particles for synchronous motion. LMU physicists now provide new insights into ...
Gold nanoparticles promise potential improvements in cancer treatment, drug delivery, and gene therapy — with one, major problem. In order for the particles to destroy a tumor or create holes ...
Biomolecules do not perform their functions alone, but interactively with one another to form so called biomolecular networks. It is well known that a complex disease stems from the malfunctions of co...
Synthetic biology has intensively promoted the technical implementation of modular strategies in the fabrication of biological devices. Modules are considered as networks of reactions. The behavior di...
To study the success of Oligodendrocyte progenitor cell culture project in Rajavithi Hospital to identify an unlimited clone human neuronal progenitor stem cells from the human brain in th...
The research leading consortium to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement no 602461 (www.biocog.eu). ...
The Association of Biomolecular Resource Facilities is an international society dedicated to advancing core and research biotechnology laboratories through research, communication, and education.
Welcome at the CMBI, which is short for Centre for Molecular and Biomolecular Informatics. The centre performs research and education, and provides services in bioinformatics and cheminformatics.
A platform nanoparticulate technology for biomolecular delivery in a broad range of industrial, personal use, and biomedical applications.
The Society for Biomolecular Sciences' mission is to advance the science of drug discovery and related disciplines by providing a forum for education and information exchange among professionals aroun...
BiOptix offers an affordable and powerful solution for drug discovery scientists that require label-free real-time detection of biomolecular interactions. The unique SPR-enhanced ...
We have published hundreds of BioMolecular Therapeutics, Inc. news stories on BioPortfolio along with dozens of BioMolecular Therapeutics, Inc. Clinical Trials and PubMed Articles about BioMolecular Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMolecular Therapeutics, Inc. Companies in our database. You can also find out about relevant BioMolecular Therapeutics, Inc. Drugs and Medications on this site too.